157 related articles for article (PubMed ID: 6133000)
1. The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.
Azad Khan AK; Nurazzaman M; Truelove SC
J Med Genet; 1983 Feb; 20(1):30-6. PubMed ID: 6133000
[TBL] [Abstract][Full Text] [Related]
2. Sulfasalazine and 5-ASA compounds.
Allgayer H
Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
[TBL] [Abstract][Full Text] [Related]
3. Sulphasalazine: drug or pro-drug?
Lancet; 1987 Jun; 1(8545):1299-301. PubMed ID: 2884417
[No Abstract] [Full Text] [Related]
4. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536
[TBL] [Abstract][Full Text] [Related]
5. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
Rachmilewitz D
BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.
Dew MJ; Ebden P; Kidwai NS; Lee G; Evans BK; Rhodes J
Br J Clin Pharmacol; 1984 Apr; 17(4):474-6. PubMed ID: 6144318
[TBL] [Abstract][Full Text] [Related]
7. Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
Teshima D; Hino B; Makino K; Yano T; Itoh Y; Joh Y; Iida M; Oishi R
J Clin Pharm Ther; 2003 Jun; 28(3):239-42. PubMed ID: 12795783
[TBL] [Abstract][Full Text] [Related]
8. The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.
Das KM; Eastwood MA; McManus JP; Sircus W
Gut; 1973 Aug; 14(8):631-41. PubMed ID: 4147555
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth.
Dew MJ; Harries AD; Evans N; Evans BK; Rhodes J
Br Med J (Clin Res Ed); 1983 Jul; 287(6384):23-4. PubMed ID: 6134565
[No Abstract] [Full Text] [Related]
10. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
Das KM; Eastwood MA; McManus JP; Sircus W
N Engl J Med; 1973 Sep; 289(10):491-5. PubMed ID: 4146729
[No Abstract] [Full Text] [Related]
11. Sulphasalazine in inflammatory bowel disease: recent advances.
Cooper BT
N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
[No Abstract] [Full Text] [Related]
12. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
Ewe K; Eckardt V; Kanzler G
Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
[TBL] [Abstract][Full Text] [Related]
13. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
[No Abstract] [Full Text] [Related]
14. 5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine.
Campieri M; Lanfranchi GA; Brignola C; Bazzocchi G; Minguzzi MR; Calari MT
Lancet; 1984 Feb; 1(8373):403. PubMed ID: 6141471
[No Abstract] [Full Text] [Related]
15. Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid.
Cann PA; Holdsworth CD
Lancet; 1984 May; 1(8386):1119. PubMed ID: 6144844
[No Abstract] [Full Text] [Related]
16. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
Klotz U
Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
[TBL] [Abstract][Full Text] [Related]
17. [Drug therapy of ulcerative colitis].
Rückert Y
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine and new analogues.
Friedman G
Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
[No Abstract] [Full Text] [Related]
19. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
Barber GB; Lee DE; Antonioli DA; Peppercorn MA
Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789
[TBL] [Abstract][Full Text] [Related]
20. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
Donald IP; Wilkinson SP
Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
